维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="SCHUCHTER L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Survival in BRAF V600-mutant advanced melanoma treated with Muraenidae显示文摘	Sosman 1 A Kim K B Schuchter L	2012	N Engl 1 Med2012，366，8：	1
2	American Society of Clinical Oncology Clincal practice guidelines for the use of chemotherapy and radiotherapy 显示文摘	HENSLEY M L SCHUCHTER L M LINDLEY C	1999	J Clin Oncol1999，17，10：	1
3	Phase Ⅰ/Ⅱ trial of BAY43-9006, carboplatin(C)and paclitax(P) demonstrates preliminary antitumor activity in the expansion cohort of patients with metastatic melanoma (abstract)显示文摘	Flaherty KT Brose M Schuchter L	2004	Proc Am Soc Clin Oncol2004，22，：	1
4	Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib显示文摘	SOSMANJA KIM KB SCHUCHTER L	2012	N EnglJ Med2012，366，8：	1
5	The current status of WR-2721(Amifostine):A chemotherapy and radiation therapy protector显示文摘	SCHUCHTER L M GLICK J		0，，03：	1
6	Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib显示文摘	Sosman JA Kim KB Schuchter L		0，，8：	1
7	Survival in BRAF V600- mutant advanced melanoma treated with vemurafenib显示文摘	Sosman J A Kim K B Schuchter L	2012	N Engl J Med2012，366，8：	1
8	Metastatic melanoma显示文摘	SUN W SCHUCHTER L M	2001	Curr Treat Options Oncol2001，2，3：	1
9	The current status of toxicity protectants in cancer therapy显示文摘	SCHUCHTER L M LUGINBUHL W E MEROPOL N J		0，，06：	1
10	Survival in BRAF 600-mutant advanced melanoma treated with vemurafenib显示文摘	Sosman JA Kim KB Schuchter L	2012	N Engl J Med2012，366，8：	1
11	American Society of Clinical Oncology? clincal practice guidelines for the use of chemotherapy and radiotherapy 显示文摘	HENSLEY SCHUCHTER L M LINDLEY C	1999	J Clin Oncol1999，17，10：	1
12	A randomized phase Ⅱ pilot trial of adjuvant marimastat in patients with early- stage breast cancer显示文摘	Miller KD Gradishar W Schuchter L	2002	Ann Onco12002，13，8：	1
13	Survival in BRAF V600-matmat advanced melanoma treated with venmrafenib 显示文摘	Sosmau JA Kim KB Schuchter L	2012	N Engl J Med2012，366，8：	1
14	Phase I/I1 trim of BAY 43 - 9006, carboplatin ( C ) and paclitaxel (P) demonstratespreliminary antitumor activity in the expansion chort of patients with metastatic melanoma显示文摘	Flaherty KT Brose M Schuchter L	2004	Proc Am Society Clin Oncol2004，23，：	1
15	A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer显示文摘	Miller KD Gradishar W Schuchter L	2002	Ann Onco12002，13，8：	1
16	Pharmacokinetics of amifostine: effects of dose and method of administration显示文摘	Bonner HS Schuchter L	1999	Semin Oncol1999，26，27：	1
17	Survival in braf v600- mutant advanced melanoma treated with vemurafenib 显示文摘	SOSMAN J A KIM K B SCHUCHTER L et at	2012	N Engl J Med2012，366，8：	1
18	Phase Ⅰ/Ⅱ trial of BAY 43-9006, earboplatin and paclitaxel demonstrates preliminary antitumor activity in the expansion cohort of patients with metastatic melanoma 显示文摘	Flaherty KT Brose M Schuchter L	2004	Journal of Clinical Oncology2004，22，14：	1
19	Survival in BRAF V600- mutant advanced melanoma treated with vemurafenib显示文摘	Sosman JA Kim KB Schuchter L	2012	N Engl J Med2012，366，：	1
20	Phase trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases 显示文摘	AMARAVADI R K SCHUCHTER L M MCDERMOTT D F	2009	Clin Cancer Res2009，15，24：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示